Trial demonstrated that PP353 delivers clinically meaningful and durable reduction in pain and disability in patients with chronic Low Back Pain and Modic Type 1 changes PP353 has the potential to ...
Persica is developing PP353, a potentially curative, opioid-sparing treatment for patients with chronic Low Back Pain Persica’s work builds on substantial evidence that chronic Low Back Pain with ...